Breast and Gynecologic Cancer Clinical Trials

Title Intervention NCT IDsort descending Sponsor Status
Phase II Study of Metformin for Reduction of Obesity-Associated Breast Cancer Risk Metformin, Placebo NCT02028221 University of Arizona Active, not recruiting
Transdermal or Oral Telapristone Acetate in Treating Patients Undergoing Mastectomy Telapristone Acetate, Placebo, Laboratory Biomarker Analysis, Questionnaire Administration NCT02314156 Northwestern University Active, not recruiting
Recombinant Human Papillomavirus Nonavalent Vaccine in Preventing Human Papilloma Virus in Younger... Laboratory Biomarker Analysis, Recombinant Human Papillomavirus Nonavalent Vaccine NCT02568566 National Cancer Institute (NCI) Active, not recruiting
Alternative Dosing of Exemestane Before Surgery in Treating Postmenopausal Patients With Stage 0-II... Exemestane, Laboratory Biomarker Analysis, Pharmacological Study, Quality-of-Life Assessment, Questionnaire Administration, Therapeutic Conventional Surgery, Placebo Administration NCT02598557 National Cancer Institute (NCI) Active, not recruiting
Nelipepimut-S Plus GM-CSF Vaccine Therapy in Treating Patients With Breast Cancer Laboratory Biomarker Analysis, Nelipepimut-S Plus GM-CSF Vaccine, Sargramostim, Surgical Procedure NCT02636582 National Cancer Institute (NCI) Active, not recruiting
Vaccine Therapy in Preventing Cancer Recurrence in Patients With Non-Metastatic, Node Positive,... Laboratory Biomarker Analysis, pUMVC3-IGFBP2-HER2-IGF1R Plasmid DNA Vaccine, Sargramostim NCT02780401 University of Washington Active, not recruiting
Retinoid 9cUAB30 in Producing a Biologic Effect in Patients With Early Stage Breast Cancer Retinoid 9cUAB30, Therapeutic Conventional Surgery NCT02876640 National Cancer Institute (NCI) Recruiting
Testing an Active Form of Tamoxifen (4-hydroxytamoxifen) Delivered Through the Breast Skin to... Afimoxifene, Laboratory Biomarker Analysis, Placebo, Tamoxifen Citrate NCT02993159 Northwestern University Recruiting
Preventive Human Papillomavirus (HPV) Vaccine Trial in Kidney Transplant Recipients Laboratory Biomarker Analysis, Questionnaire Administration, Recombinant Human Papillomavirus Nonavalent Vaccine NCT03036930 National Cancer Institute (NCI) Active, not recruiting
Afimoxifene in Reducing the Risk of Breast Cancer in Women With Mammographically Dense Breast Afimoxifene, Laboratory Biomarker Analysis, Placebo, Questionnaire Administration NCT03063619 M.D. Anderson Cancer Center Recruiting

Pages